NORMAL SITUATION

Eurobio Scientific Benelux

Company — Normal situation.

Financial year 2025 · Closed on 23/10/2025

Net result-19,9 k €+15,1 %over 1 year
Gross margin-10,9 k €-74,2 %over 1 year
Equity174,3 k €-10,3 %over 1 year

Identity

Source · BCE/KBO

Eurobio Scientific Benelux is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0424.732.712
Legal form
Public limited company
Contributed capital
413 258,34 €
Latest accounts
23/10/2025
Signals
Solid equity

Financials

Source · NBB, 42 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin-10,9 k €-6,2 k €-8,1 k €-50,8 k €-36,5 k €
EBITDA-11,7 k €-6,8 k €-8,9 k €-89 k €-36,8 k €
Operating result-11,7 k €-6,8 k €-8,9 k €-89 k €-36,8 k €
Net result-19,9 k €-23,5 k €-25,2 k €-99 k €-37,4 k €
Balance sheet
Equity174,3 k €194,2 k €217,6 k €242,9 k €341,9 k €
Total assets174,3 k €3,5 M €3,5 M €3,5 M €357,3 k €
Cash1,9 k €9,2 k €10,4 k €72,1 k €141,7 k €
Debts–3,3 M €3,3 M €3,3 M €15,4 k €
Other
Workforce–––––

Board of directors

Source · NBB, accounts to 23/10/2025

2 active · 22 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
EUROBIO SCIENTIFIC SARepresented by Hervé DUCHESNE DELAMOTTE
Directorsince 25/05/2018
Hervé Duchesne De Lamotte
Director

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
DIAXONHIT SARepresented by Hervé DUCHESNE DELAMOTTE
Director08/06/2017 → 31/05/2024
Hervé DUCHESNE DELAMOTTE
Director25/05/2018 → 31/05/2024
Loïc MAUREL
Director15/12/2015 → 07/06/2017

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year23/10/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year10 months12 months12 months12 months12 months12 months
Filing date12/11/202505/06/202513/06/202416/06/202330/08/202222/07/2021
General meeting23/10/202516/05/202517/05/202419/05/202327/05/202228/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 42 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model23/10/202523/10/202512/11/2025DutchPDF
Abridged model31/12/202416/05/202505/06/2025DutchPDF
Abridged model31/12/202317/05/202413/06/2024DutchPDF
Abridged model31/12/202219/05/202316/06/2023DutchPDF
Abridged model31/12/202127/05/202230/08/2022FrenchPDF
Abridged model31/12/202028/05/202122/07/2021FrenchPDF
Abridged model31/12/201929/05/202019/06/2020FrenchPDF
Abridged model31/12/201831/05/201921/06/2019FrenchPDF
Abridged model31/12/201725/05/201807/08/2018FrenchPDF
Abridged model31/12/201626/05/201721/08/2017FrenchPDF
Abridged model31/12/201527/05/201610/06/2016FrenchPDF
Abridged model31/12/201429/05/201505/08/2015FrenchPDF
Abridged model31/12/201330/05/201408/07/2014FrenchPDF
Abridged model31/12/201231/05/201331/05/2013FrenchPDF
Abridged model31/12/201125/05/201206/06/2012FrenchPDF
Abridged model31/12/201027/05/201107/06/2011FrenchPDF
Abridged model31/12/200928/05/201031/05/2010FrenchPDF
Abridged model31/12/200829/05/200902/06/2009FrenchPDF
Abridged model31/12/200730/05/200813/06/2008FrenchPDF
Abridged model31/12/200625/05/200721/06/2007FrenchPDF
Abridged model31/12/200526/05/200624/08/2006FrenchPDF
Abridged model31/12/200401/06/200515/07/2005FrenchPDF
Abridged model31/12/200309/06/200420/10/2004FrenchPDF
Abridged model31/12/200212/06/200328/08/2003FrenchPDF
Abridged model31/12/200103/06/200214/11/2002FrenchPDF
Abridged model31/12/200012/05/200130/11/2001FrenchPDF
Abridged model31/12/199912/05/200011/10/2000FrenchPDF
Abridged model31/12/199830/04/199928/09/1999FrenchPDF
Abridged model31/12/199703/06/199810/07/1998French—
Abridged model31/12/199629/05/199720/08/1997French—
Abridged model31/12/199510/05/199629/08/1996French—
Abridged model31/12/199426/05/199524/11/1995French—
Abridged model31/12/199327/05/199429/11/1994French—
Abridged model31/12/199230/04/199318/02/1994French—
Abridged model31/12/199124/04/199212/11/1992French—
Abridged model31/12/199026/04/199117/12/1991French—
Abridged model31/12/198927/04/199014/01/1991French—
Abridged model31/12/198829/04/198931/10/1989French—
Abridged model31/12/198729/04/198826/12/1988French—
Abridged model31/12/198624/04/198714/10/1987French—
Abridged model31/12/198526/04/198602/01/1987French—
Abridged model31/12/198426/04/198520/11/1985English—

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 23/10/2025

2 active · 22 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
EUROBIO SCIENTIFIC SARepresented by Hervé DUCHESNE DELAMOTTE
Directorsince 25/05/2018
Hervé Duchesne De Lamotte
Director

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
DIAXONHIT SARepresented by Hervé DUCHESNE DELAMOTTE
Director08/06/2017 → 31/05/2024
Hervé DUCHESNE DELAMOTTE
Director25/05/2018 → 31/05/2024
Loïc MAUREL
Director15/12/2015 → 07/06/2017

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution05/12/2025
    BUITENGEWONE ALGEMENE VERGADERING — ONTBINDING EN
    PDF
  • Restructuring03/07/2024
    Fusievoorstel
    PDF
  • Mandates26/06/2024
    Benoeming commissaris
    PDF
  • Other27/01/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Registered office27/12/2022
    SIEGE SOCIAL
    PDF
  • Mandates08/07/2022
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DENOMINATION - OBJET - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates05/11/2018
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates18/09/2017
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Name
Registered office
Annual accounts
Filings20 filings
Mandates
DIAXONHIT SA
EUROBIO SCIENTIFIC SA
Hervé DUCHESNE DELAMOTTE
Loïc MAUREL
DIAXONHIT
Patrick MOLLET
INGEN BIOSCIENCES
INNOVEN PARTENAIRES
Isabelle BUCKLE
Jean-Pierre HERMET
ZENTECH
NOSHAQ PARTNERS
and 11 more mandates
200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026
Eurobio Scientific Benelux
Noorderlaan 139, 2030 Antwerp-2030
Director
Director
Director
Director
Director
Director
Director
Director
Director
Director
DirectorManaging director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Noorderlaan 139, 2030 Antwerp-2030
accounts 2022 → 2025
Accounts 2025 · 2025-00565457
Voie de l'Air Pur 17-19, 4052 Beaufays
accounts 2021
Accounts 2021 · 2022-20346625

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Eurobio Scientific Benelux
accounts 2022 → 2025
Accounts 2025 · 2025-00565457
GAMMA
accounts 2021
Accounts 2021 · 2022-20346625

Events

  1. 2025
    Annual accounts 2025-19,9 k €↑
  2. 2024
    Annual accounts 2024-23,5 k €↑
  3. 2023
    Annual accounts 2023-25,2 k €↑
  4. 2022
    Annual accounts 2022-99 k €↓
  5. 2022
    Name changeEurobio Scientific Benelux
  6. 2021
    Annual accounts 2021-37,4 k €↓
  7. 2020
    Annual accounts 20202,4 k €↓
  8. 2019
    Annual accounts 201955,4 k €↓
  9. 2018
    Annual accounts 201878,5 k €↓
  10. 2017
    Annual accounts 201794,8 k €↑
  11. 2016
    Annual accounts 201693,7 k €↑
  12. 2015
    Annual accounts 20154,8 k €↓
  13. 2014
    Annual accounts 201421,6 k €↓
  14. 2013
    Annual accounts 201328,4 k €↓
  15. 2012
    Annual accounts 201233,3 k €↑
  16. 2011
    Annual accounts 201121,9 k €↓
  17. 2010
    Annual accounts 201032,5 k €↑
  18. 2009
    Annual accounts 20093 k €↓
  19. 2008
    Annual accounts 200813,3 k €↑
  20. 2007
    Annual accounts 20079,9 k €↑
  21. 2006
    Annual accounts 2006-288,9 k €